Viewing Study NCT03218969


Ignite Creation Date: 2025-12-24 @ 10:48 PM
Ignite Modification Date: 2026-04-25 @ 3:43 PM
Study NCT ID: NCT03218969
Status: UNKNOWN
Last Update Posted: 2018-07-24
First Post: 2017-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist
Sponsor: William Ondo, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module